Announcements Trials
Browse Landscape

Phase

Phase NA 64Phase 2 5Phase 1 5Phase 4 3Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 3Thoracic 2Breast 2Other hematologic neoplasm 1

Conditions

Pain, Postoperative 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 16Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Gemcitabine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Drug Therapy 5Control Groups 5Cisplatin 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Sodium Chloride 4Ropivacaine 4Ribavirin 4Hepatectomy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Blood Specimen Collection × Gastrointestinal × Clear all
NCT03570541 2021-01-15

TQL-block for Laparoscopic Hemicolectomy

Zealand University Hospital

Phase 4 Completed
69 enrolled
Gastrointestinal

Colonic Neoplasms, Pain, Postoperative

NCT00911092 2012-01-02

COL06-13

Centre Oscar Lambret

Phase 4 Completed
50 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00140036 2008-03-03

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Pfizer

Phase 4 Completed
137 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡